Effectiveness of Major Ozone Autohemotherapy in the Treatment of Fibromyalgia Syndrome

Effectiveness of Major Ozone Autohemotherapy in the Treatment of Fibromyalgia Syndrome

Patients who were admitted to the Physical Medicine and Rehabilitation (PMR) outpatient clinic of our hospital between January 2017 and December 2020 and were treated with Major ozone autohemotherapy with a diagnosis of Fibromyalgia syndrome will include to the study. Visual anolog scale (VAS), Fibromyalgia Impact Questionnare (FIQ) and Short Form Health Survey-36 (SF-36) scores of the patients before and after treatment were recorded. Statistical analysis of these outcome scores will be made.

Exclusion Criteria:

• has pregnancy,
• has primary romatological disease,
• has primary psychiatric disease
• <18, >60 years old patients